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The liver was among the first organs in which connexin proteins have been identified.
Hepatocytes harbor connexin32 and connexin26, while non-parenchymal liver cells
typically express connexin43. Connexins give rise to hemichannels, which dock with
counterparts on adjacent cells to form gap junctions. Both hemichannels and gap junctions
provide pathways for communication, via paracrine signaling or direct intercellular
coupling, respectively. Over the years, hepatocellular gap junctions have been shown to
regulate a number of liver-specific functions and to drive liver cell growth. In the last few
years, it has become clear that connexin hemichannels are involved in liver cell death,
particularly in hepatocyte apoptosis. This also holds true for hemichannels composed of
pannexin1, a connexin-like protein recently identified in the liver. Moreover, pannexin1
hemichannels are key players in the regulation of hepatic inflammatory processes. The
current paper provides a concise overview of the features of connexins, pannexins and
their channels in the liver.
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INTRODUCTION
The liver is a unique organ endowed with a plethora of specialized
functions and a strong regenerative capacity. The establishment
of communicative networks between the different liver cell types
is therefore indispensable. Non-parenchymal liver cells preferen-
tially have paracrine or juxtacrine contacts amongst themselves
and with other hepatic cell types (Kmiec´, 2001). Hepatocytes, the
most prominent liver cell population, directly communicate with
each other through gap junctions. The latter are formed by head-
to-head docking of 2 hemichannels of neighboring cells, which
in turn are composed of 6 connexin (Cx) proteins (Figure 1)
(Vinken et al., 2006, 2008, 2009, 2010a,b, 2011; Decrock et al.,
2009, 2011). Historically, these hemichannels have been consid-
ered as merely structural precursors of gap junctions. In the last
decade, an accumulating body of evidence points to indepen-
dent roles for hemichannels in cellular signaling by connecting
the intracellular compartment with the extracellular environ-
ment (Vinken et al., 2006, 2010b; Decrock et al., 2009, 2011).
More recently, a novel class of connexin-like proteins, the pan-
nexin (Panx) proteins, has been identified. They assemble in a
hemichannel configuration and are also named “single mem-
brane channels” instead of hemichannels, as they do not appear
to form gap junctions (D’Hondt et al., 2011; Bennett et al.,
2012; Dahl and Keane, 2012; Wang et al., 2013a). In contrast to
gap junctions, connexin and pannexin hemichannels seem to be
mainly involved in pathological processes, including cell death
Abbreviations: ATP, adenosine 5′ triphosphate; Cx, connexin; GJIC, gap junc-
tional intercellular communication; IP3, inositol triphosphate; P2X7R, P2X7 recep-
tors; Panx, pannexin; UTP, uridine 5′ triphosphate.
and inflammation (Decrock et al., 2009; D’Hondt et al., 2009;
Chekeni et al., 2010; Ganz et al., 2011; Bennett et al., 2012).
These emerging roles for connexin and pannexin hemichannels
are discussed in the present paper with focus on their relevance
to liver (dys)functionality. Furthermore, an updated overview of
the currently available knowledge regarding hepatic connexin and
pannexin expression as well as liver gap junctions is provided.
CONNEXINS AND PANNEXINS IN THE LIVER
At present, more than 20 connexin proteins have been iden-
tified in human beings and rodents. They all share a similar
structure consisting of 4 membrane-spanning domains, 2 extra-
cellular loops, a cytoplasmic loop, and cytosolic N-terminal
and C-terminal regions (Figure 1). The different connexin fam-
ily members are typically named after their molecular weight
expressed in kilodaltons (Decrock et al., 2009; Vinken et al.,
2009). Hepatocytes express Cx32 and to a lesser extent Cx26,
which represents about 90 and 5%, respectively, of the total
connexin amount in rat and human livers. In contrast, most
non-parenchymal liver cells, including stellate cells and Kupffer
cells, mainly harbor Cx43, while liver vascular cells predomi-
nantly express Cx37 and Cx40 (Figure 2) (Kumar and Gilula,
1986; Paul, 1986; Nicholson et al., 1987; Zhang and Nicholson,
1989; Chaytor et al., 2001; Bode et al., 2002; Fischer et al., 2005;
Shiojiri et al., 2006). A typical hallmark of the liver includes zona-
tion, which is also manifested at the connexin level. Indeed, Cx32
is uniformly distributed throughout the liver, whereas Cx26 is
preferentially expressed in the periportal acinar area (Berthoud
et al., 1992; Kojima et al., 1995; Iwai et al., 2000). Liver connexin
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FIGURE 1 | (A) Molecular architecture of gap junctions. Gap junctions are
grouped in plaques at the cell plasma membrane surface of 2 adjacent cells
and are composed of 12 connexin proteins organized as 2 hexameric
hemichannels. The connexin protein consists of 4 membrane-spanning
domains (TM), 2 extracellular loops (EL), 1 cytoplasmic loop (CL), 1
cytoplasmic aminotail (NT) and 1 cytoplasmic carboxytail (CT) (EC,
extracellular; IC, intracellular) (Vinken et al., 2008; Decrock et al., 2009). (B)
Structural comparison of connexins and pannexins (Chekeni et al., 2010).
FIGURE 2 | Connexins and pannexins expressed in the liver.
Schematic overview of the most relevant connexin and pannexin
species expressed in rodent and human livers (Kumar and Gilula,
1986; Paul, 1986; Nicholson et al., 1987; Zhang and Nicholson, 1989;
Chaytor et al., 2001; Bode et al., 2002; Fischer et al., 2005; Shiojiri
et al., 2006; Xiao et al., 2012).
expression patterns undergo drastic changes upon both differen-
tiation (i.e., liver organogenesis) and dedifferentiation (i.e., liver
disease) (Vinken, 2012; Vinken et al., 2008, 2012a). Specifically,
early hepatic progenitor cells switch from Cx43 to Cx26, but espe-
cially to Cx32 during differentiation into hepatocytes (Zhang and
Thorgeirsson, 1994; Neveu et al., 1995; Naves et al., 2001; Paku
et al., 2004). An inverse process is observed when chronic liver
disease, such as liver fibrosis and cirrhosis, progressively turns
into liver cancer (Vinken, 2012). Moreover, connexin expression
and subcellular localization are significantly altered during liver
cell growth (Traub et al., 1983; Kren et al., 1993; Temme et al.,
2000). Proliferation is a rare event in the adult liver, but upon par-
tial hepatectomy, the remaining liver lobes start to grow and the
original size becomes restored within a week (Taub, 2004). Cx32
expression was found to increase during early hepatocyte cell
cycling, followed by a sharp decline (Traub et al., 1983; Dermietzel
et al., 1987; Sugiyama and Ohta, 1990; Miyashita et al., 1991; Kren
et al., 1993; Temme et al., 2000; Kojima et al., 2003). Less con-
sistent changes have been reported for Cx26 (Kren et al., 1993;
Temme et al., 2000). Furthermore, Cx37 and Cx40 are clearly
upregulated, while Cx43 tends to stay unaffected during liver
regeneration (Kren et al., 1993).
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Only 3 pannexin proteins have yet been characterized. They
show structural similarity with connexin proteins, though pan-
nexins typically have longer C-terminal regions and extracellular
loops (D’Hondt et al., 2011; Wang et al., 2013a). Unlike connex-
ins, very little is known about the occurrence of pannexins in
the liver, although a number of studies have demonstrated the
presence of Panx1 (Bruzzone et al., 2003; Csak et al., 2011; Ganz
et al., 2011). In a more recent study, Panx1 mRNA was detected in
cultured rat primary hepatocytes as well as in rat and human can-
cerous hepatocytes (Xiao et al., 2012). A single study also showed
expression of Panx2 in the lateral plasma membrane fraction of
primary rat hepatocytes (Li et al., 2008).
GAP JUNCTIONS IN THE LIVER
In the liver, the vast majority of gap junctions are formed between
hepatocytes. They occupy as much as 3% of the hepatocellular
membrane surface and form gap junctional plaques ranging from
0.2 to 1µm in diameter and containing from 10 to more than
10,000 gap junction channels. Hepatocellular gap junctions in the
pericentral acinar area mainly consist of homomeric hemichan-
nels (i.e., containing Cx32), whereas their periportal counterparts
can also be built up by heteromeric hemichannels (i.e., com-
posed of both Cx26 and Cx32) (Vinken et al., 2008). Cx32 in
the liver interacts with several other junctional proteins, such as
occludin and claudin1 (Kojima et al., 2001), but also with mito-
chondrial proteins, including sideroflexin1 (Fowler et al., 2013).
Gap junctions provide a generic pathway for communication
between adjacent cells, called gap junctional intercellular com-
munication (GJIC). GJIC includes the passive diffusion of small
and hydrophilic molecules, such as cyclic adenosine monophos-
phate, adenosine 5’ triphosphate (ATP), inositol triphosphate
(IP3) and ions (Alexander and Goldberg, 2003; Dbouk et al.,
2009; Decrock et al., 2009; Vinken et al., 2011). Homotypic Cx26
gap junctions favor cation transfer, whereas homotypic Cx32
gap junctions promote anion passage (Bukauskas et al., 1995).
Likewise, ATP passes significantly better through gap junctions
formed by Cx43 compared to Cx32-based channels (Goldberg
et al., 2002).
Hepatocellular gap junctions are indispensable for main-
taining the metabolic competence of the liver. In particular,
Cx32-based GJIC underlies a number of liver-specific functions,
including glycogenolysis (Stumpel et al., 1998), albumin secretion
(Yang et al., 2003), bile secretion (Temme et al., 2001), ammonia
detoxification (Yang et al., 2003) and xenobiotic biotransforma-
tion (Neveu et al., 1994; Shoda et al., 1999, 2000). Curiously,
genetic ablation of Cx26 and Cx32 in mice does not drastically
alter basal liver functionality (Ott et al., 2006). In line with this
finding, Cx26 gene mutations in humans have been associated
with skin diseases and deafness, but not with abnormalities in
the liver (Lee and White, 2009), yet these patients display a gain
of Cx26 hemichannel function (Mhaske et al., 2013). Similarly,
human Cx32 gene mutations typically lead to neurological dis-
orders, while leaving the liver largely unaffected (Abrams et al.,
2000). However, Cx32-deficient mice, unlike their Cx26-lacking
counterparts (Marx-Stoelting et al., 2008), have been found more
susceptible to spontaneously occurring and chemically induced
hepatocarcinogenesis (Temme et al., 1997).
The biochemical identity of the messengers that travel through
hepatocyte gap junctions and that affect liver functionality
remains largely elusive, though an exception exists for glycogenol-
ysis. Breakdown of glycogen to glucose is triggered by hormonal
and neuronal stimuli and predominantly occurs at the peripor-
tal acinar pole. Pericentral hepatocytes also show glycogenolytic
activity, albeit to a lesser extent (Stumpel et al., 1998; Saez et al.,
2003). Cx32-based gap junctions therefore drive the propagation
of the glycogenolytic response from the periportal to the peri-
central area. In fact, they facilitate the intercellular exchange of
IP3, which activates calcium release from endoplasmic reticu-
lum stores, in turn evoking calcium waves throughout the acinar
tract (Clair et al., 2001; Saez et al., 2003; Gaspers and Thomas,
2005). Indeed, Cx32 knock-out mice display lowered blood glu-
cose levels upon glycogenolytic stimulation (Nelles et al., 1996;
Stumpel et al., 1998). Similarly, the spread of calcium waves
through Cx43-based gap junctions controls ductular secretion
from cholangiocytes and thus bile formation (Nathanson et al.,
1999; Bode et al., 2002).
GJIC is clearly involved in liver cell growth. However, the exact
role and overall relevance of gap junctions in hepatocyte cell
cycling is matter of debate. In the regenerating liver of rats treated
with an inhibitor of the mitogen-activated protein kinase path-
way, the reduction of Cx32 production is counteracted, with no
effects on hepatocyte proliferative activity (Kojima et al., 2003).
This indicates that downregulation of GJIC may occur indepen-
dently of hepatocyte proliferation. In the regenerating liver of
Cx32 knock-out mice, hepatocellular proliferative activity is not
affected, but the extent of synchronous initiation and termination
of DNA synthesis is decreased (Kojima et al., 1997; Temme et al.,
2000). Based on this observation, reduction of GJIC does not pro-
vide a direct signal for hepatocytes to divide, but rather permits
cell cycle progression upon mitogenic stimulation. On the other
hand, a plethora of studies have shown determinate functions
for gap junctions in liver cell proliferation control, rather than
merely an assisting role in growth progression (Koffler et al., 2000;
Ruch, 2000; Yano et al., 2001). It should be stressed, however, that
such studies typically rely on genetic ablation of connexin expres-
sion, thus impeding discrimination between GJIC and connexin
hemichannel communication.
CONNEXIN AND PANNEXIN HEMICHANNELS IN THE LIVER
Although still surrounded by a lot of controversy, it is now
accepted that connexin hemichannels autonomously establish a
pathway for cellular signaling between the cytosol of individual
cells and their extracellular environment (Decrock et al., 2009;
Chandrasekhar and Bera, 2012; Kar et al., 2012). The messen-
gers that diffuse through connexin hemichannels are very similar
to those that can permeate gap junctions and typically include
ATP, glutamate and glutathione. However, in contrast to gap
junctions, connexin hemichannels have a low probability to be
open. They can be opened by a number of stimuli that are of
pathological origin, such as changes in extracellular or intracel-
lular calcium concentration, oxidative stress, induced metabolic
inhibition, ischemia/reperfusion insults and inflammatory con-
ditions. Hence, connexin hemichannels are frequently referred
to as pathological pores (Decrock et al., 2009; Chandrasekhar
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and Bera, 2012; Kar et al., 2012). This has been well exempli-
fied in the context of cell death. Although a limited set of reports
described cytoprotective functions for connexin hemichannels
(Plotkin et al., 2002; Okuda et al., 2013), most scientific evidence
available points to pro-active roles for connexin hemichannels in
the cell death process, involving the formation of a toxic pore or
contributing to a paracrine cell death pathway (Kalvelyte et al.,
2003; Takeuchi et al., 2006; Ramachandran et al., 2007; Decrock
et al., 2009). Connexin hemichannels not only occur at the plasma
membrane surface, but also reside at other subcellular locations,
such as the mitochondria, where they have been linked to cell sur-
vival (Goubaeva et al., 2007; Lu et al., 2010; Azarashvili et al.,
2011; Trudeau et al., 2012; Fowler et al., 2013). In this context,
Cx43 translocates to the mitochondria where it interacts with
Bax to initiate the mitochondrial apoptotic pathway in pancreatic
cancer cells (Sun et al., 2012). Furthermore, mitochondrial Cx43
plays a role in myocardial ischemia-reperfusion injury by inter-
fering with reactive oxygen species signaling (Ruiz-Meana et al.,
2008) and facilitates ATP production (Boengler et al., 2012).More
recently, mitochondrial Cx43-based hemichannels were found to
assist in mitochondrial potassium uptake (Boengler et al., 2013).
Our group was the first to show the functional presence of
connexin hemichannels in hepatocytes. Upon induction of Fas-
mediated apoptosis in cultures of primary hepatocytes, GJIC
rapidly declines, which is associated with a decay of the gap
junctional Cx32 protein pool. At the same time, levels of newly
synthesized Cx32 protein increase and gather in a hemichannel
configuration. This becomes particularly evident toward the end
stages of the cell death process (Vinken et al., 2010c). Subsequent
experiments showed that Cx32-based hemichannels facilitate the
apoptotic-to-necrotic transition in hepatocytes. Primary hepato-
cytes in culture are known to progressively lose their differenti-
ated status, whereby Cx43 becomes de novo produced. Work with
specific channel inhibitors demonstrated that Cx43 signaling,
also involving hemichannels, underlies the onset of spontaneous
apoptosis, which accompanies the dedifferentiation process in
cultures of primary hepatocytes (Vinken et al., 2012b). In a more
recent study, Cx43 production in cultured hepatocytes was epi-
genetically silenced followed by global protein and metabolite
profiling. Among the proteins altered were several mitochondrial
proteins. These data thus could further substantiate the existence
of a mitochondrial connexin pool, and can be reconciled with a
role for Cx43 signaling in spontaneously occurring apoptosis in
primary hepatocyte cultures (Vinken et al., 2013).
Pannexin hemichannels have also been identified as media-
tors of apoptotic processes (Chekeni et al., 2010; Qu et al., 2011;
Sandilos et al., 2012). Pannexin hemichannels can be opened by
various pathological stimuli such as oxygen glucose deprivation,
metabolic inhibition and S-nitrosylation (Thompson et al., 2006;
Zhang et al., 2008). Similar to connexins (Yin et al., 2001; Theiss
et al., 2007), Panx1 is an established target for caspases, which
results in the formation of a constitutively open channel and the
release of the so-called “find-me” signals, such as ATP and uridine
5′ triphosphate (UTP), at the earliest stages of cell death in order
to recruit phagocytes (Chekeni et al., 2010; Sandilos et al., 2012).
Both nucleotides act as “damage-associated molecular patterns,”
which are released during immunogenic cell death and serve as a
signal to initiate and amplify cell death as well as to induce inflam-
mation (Elliott et al., 2009; Chekeni et al., 2010). In fact, Panx1
plays a major role in the regulation of inflammatory processes
and thus in innate immunity. Panx1 is instrumental for activat-
ing the inflammasome, a multiprotein complex involved in innate
immunity and caspase 1 activation, and subsequent processing
and release of the pro-inflammatory cytokines interleukin 1 beta
and interleukin 18. Activation of the inflammasome has been
seen in lipopolysaccharide-stimulatedmacrophages (Pelegrin and
Surprenant, 2006, 2007) as well as in astrocytes and neurons
(Silverman et al., 2009). Further investigation demonstrated that
Panx1 hemichannel opening, induced by ATP stimulation of P2X7
receptors (P2X7R), facilitates the entry of bacterial inflamma-
tory signals into the cytosol (Kanneganti et al., 2007). Panx1 is
known to co-localize with the P2X7R and to form a “death recep-
tor” complex (Locovei et al., 2007). Here, prolonged stimulation
of the P2X7R results in the opening of a non-selective pore that
may correspond to the Panx1 hemichannel. Extracellular ATP acts
on the P2X7R, leading to Panx1 hemichannel opening (Pelegrin
and Surprenant, 2006, 2007; Locovei et al., 2007; Iglesias et al.,
2008). This mechanism may also apply for connexins, since Cx43
and P2X7R were seen to co-localize and co-immunoprecipitate in
mouse macrophages and J774 cells (Fortes et al., 2004). However,
a more recent study based on the use of Panx1−/− mice and
P2X7R−/− mice demonstrated that Panx1 and the P2X7R func-
tion in distinct signaling pathways. Whereas only the P2X7R
was necessary for inflammatory responses in lipopolysaccharide-
primed macrophages, Panx1 was dispensable in the migrating
phagocyte but was essential for the release of the “findme” signals
from apoptotic cells to recruit macrophages (Qu et al., 2011).
Treatment of mice with lipopolysaccharide, results in elevated
levels of Panx1 in the liver. Also, an increased production of
active interleukin 1 beta and interleukin 18 is observed under
these circumstances (Ganz et al., 2011). In addition to driving
the inflammasome, Panx1 contributes to pathophysiological ATP
release in lipoapoptosis induced by saturated free fatty acids, a key
morphologic and pathological feature of human non-alcoholic
steatohepatitis. Using a rat liver cell line, it has been shown that
saturated free fatty acids increase extracellular ATP concentra-
tions. Extracellular ATP release as well as cytosolic uptake of an
indicator dye were partly inhibited by suppressing Panx1 expres-
sion (Xiao et al., 2012). Thus, Panx1-based hemichannels may
play an important role in hepatic inflammation by mediating an
increase in extracellular ATP levels in lipotoxic liver injury.
CONCLUSIONS AND PERSPECTIVES
Although still being in its infancy, it has become clear in the last
few years that connexin and pannexin hemichannels fulfill critical
functions in the regulation of cell death and inflammation. Only a
handful of published reports have addressed these features in the
liver and all of those rely on the use of in vitro settings (Decrock
et al., 2009; D’Hondt et al., 2009; Chekeni et al., 2010; Ganz et al.,
2011). Although some physiological roles have been attributed to
hemichannels (Penuela et al., 2013), this remains to be demon-
strated in the liver. It will be challenging in the upcoming years to
evaluate the in vivo relevance of hepatic connexin and pannexin
hemichannels. Several liver diseases, such as hepatitis, fibrosis and
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cholestasis, are associated not only with the onset of cell death and
inflammation, but also with modifications in connexin expres-
sion patterns and activity (Vinken, 2012). In fact, as discussed in
the current paper, it is conceivable to assume that connexin, but
especially, pannexin hemichannels drive the process of hepatocyte
cell demise by releasing “find me” signals to initiate their clear-
ance (Chekeni et al., 2010). Furthermore, recent data suggest the
critical involvement of Panx1 hemichannels in liver inflammation
(Ganz et al., 2011; Xiao et al., 2012). The knowledge that will be
gained in this respect in the upcoming years could open new per-
spectives for clinical therapy. Thus far, 2 studies have pinpointed
the potential of interfering with hepatic connexin signaling in the
clinical management of acute (Patel et al., 2012) and acute-on-
chronic liver failure (Balasubramaniyan et al., 2013). However,
these studies did not distinguish between GJIC and connexin
hemichannel communication. Given the opposite roles of gap
junctions and connexin hemichannels in the (dys)regulation of
the homeostatic balance in the liver, such discrimination is key
for a targeted and efficient clinical outcome. Specific and in vivo-
applicable connexin hemichannel inhibitors have become avail-
able only very recently (Iyyathurai et al., 2013;Wang et al., 2013b).
In this respect, a peptide called Gap19 was found to specifically
block Cx43-based hemichannel signaling and to reduce cell death
in a mouse model of cardiac ischemia/reperfusion insult (Wang
et al., 2013c). Future efforts should be focused on the further
development of such tools as well as on the testing of their clinical
applicability, stressing the importance of the field of hepatology.
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